![](/img/cover-not-exists.png)
Safety and early treatment effects of the CXCR2 antagonist SB-656933 in patients with cystic fibrosis
Moss, Richard B., Mistry, Sunil J., Konstan, Michael W., Pilewski, Joseph M., Kerem, Eitan, Tal-Singer, Ruth, Lazaar, Aili L.Volume:
12
Language:
english
Journal:
Journal of Cystic Fibrosis
DOI:
10.1016/j.jcf.2012.08.016
Date:
May, 2013
File:
PDF, 734 KB
english, 2013